BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 29343623)

  • 1. Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus.
    Moinova HR; LaFramboise T; Lutterbaugh JD; Chandar AK; Dumot J; Faulx A; Brock W; De la Cruz Cabrera O; Guda K; Barnholtz-Sloan JS; Iyer PG; Canto MI; Wang JS; Shaheen NJ; Thota PN; Willis JE; Chak A; Markowitz SD
    Sci Transl Med; 2018 Jan; 10(424):. PubMed ID: 29343623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation Biomarker Panel Performance in EsophaCap Cytology Samples for Diagnosing Barrett's Esophagus: A Prospective Validation Study.
    Wang Z; Kambhampati S; Cheng Y; Ma K; Simsek C; Tieu AH; Abraham JM; Liu X; Prasath V; Duncan M; Stark A; Trick A; Tsai HL; Wang H; He Y; Khashab MA; Ngamruengphong S; Shin EJ; Wang TH; Meltzer SJ
    Clin Cancer Res; 2019 Apr; 25(7):2127-2135. PubMed ID: 30670490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The molecular genetic alterations in mucosa of intestines as markers of oncologic progression and estimate of effectiveness of anti-reflux operations in patients with Barrett's esophagus].
    Osminin SV; Vetshev FP; Rudenko VV; Zaletaev DV; Khorobrykh TV; Nemtsova MV
    Klin Lab Diagn; 2016 Oct; 61(10):681-5. PubMed ID: 30615323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation panel is a diagnostic biomarker for Barrett's oesophagus in endoscopic biopsies and non-endoscopic cytology specimens.
    Chettouh H; Mowforth O; Galeano-Dalmau N; Bezawada N; Ross-Innes C; MacRae S; Debiram-Beecham I; O'Donovan M; Fitzgerald RC
    Gut; 2018 Nov; 67(11):1942-1949. PubMed ID: 29084829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant vimentin methylation is characteristic of upper gastrointestinal pathologies.
    Moinova H; Leidner RS; Ravi L; Lutterbaugh J; Barnholtz-Sloan JS; Chen Y; Chak A; Markowitz SD; Willis JE
    Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):594-600. PubMed ID: 22315367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.
    Agarwal A; Polineni R; Hussein Z; Vigoda I; Bhagat TD; Bhattacharyya S; Maitra A; Verma A
    Int J Clin Exp Pathol; 2012; 5(5):382-96. PubMed ID: 22808291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Screening Tests for Barrett's Esophagus.
    Codipilly DC; Iyer PG
    Curr Gastroenterol Rep; 2019 Jul; 21(9):42. PubMed ID: 31346777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylated B3GAT2 and ZNF793 Are Potential Detection Biomarkers for Barrett's Esophagus.
    Yu M; O'Leary RM; Kaz AM; Morris SM; Carter KT; Chak A; Chandar A; Willis JE; Moinova HR; Markowitz SD; Brenner DE; Anandabapasathy S; Westerhoff M; Wong CJ; Shaheen NJ; Chen Y; Barnholtz-Sloan JS; Grady WM
    Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1890-7. PubMed ID: 26545406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
    Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic biomarkers in esophageal cancer.
    Kaz AM; Grady WM
    Cancer Lett; 2014 Jan; 342(2):193-9. PubMed ID: 22406828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NON-ENDOSCOPIC ESOPHAGEAL SAMPLING DEVICE AND BIOMARKER PANEL FOR DETECTION OF BARRETT'S ESOPHAGUS (BE) AND ESOPHAGEAL ADENOCARCINOMA (EAC).
    Moinova HR; Verma S; Dumot J; Faulx A; Iyer PG; Canto MI; Wang JS; Shaheen NJ; Thota PN; Aklog L; Willis JE; Markowitz SD; Chak A
    medRxiv; 2023 Sep; ():. PubMed ID: 37333176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma.
    Zou H; Osborn NK; Harrington JJ; Klatt KK; Molina JR; Burgart LJ; Ahlquist DA
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):830-4. PubMed ID: 15824152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus.
    Makita K; Kitazawa R; Semba S; Fujiishi K; Nakagawa M; Haraguchi R; Kitazawa S
    World J Gastroenterol; 2013 Jan; 19(4):536-41. PubMed ID: 23382633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global DNA methylation patterns in Barrett's esophagus, dysplastic Barrett's, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use.
    Kaz AM; Wong CJ; Varadan V; Willis JE; Chak A; Grady WM
    Clin Epigenetics; 2016; 8():111. PubMed ID: 27795744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrett's Esophagus and Esophageal Adenocarcinoma Biomarkers.
    Grady WM; Yu M; Markowitz SD; Chak A
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2486-2494. PubMed ID: 33093162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated cytological detection of Barrett's neoplasia with infrared spectroscopy.
    Old O; Lloyd G; Isabelle M; Almond LM; Kendall C; Baxter K; Shepherd N; Shore A; Stone N; Barr H
    J Gastroenterol; 2018 Feb; 53(2):227-235. PubMed ID: 28501919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of brush cytology in the diagnosis of Barrett's esophagus: an analysis of eight cases.
    Padmavathy F; Siddaraju N; Sistla SC
    Diagn Cytopathol; 2011 Jan; 39(1):60-4. PubMed ID: 21162095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression.
    Hamilton JP; Sato F; Jin Z; Greenwald BD; Ito T; Mori Y; Paun BC; Kan T; Cheng Y; Wang S; Yang J; Abraham JM; Meltzer SJ
    Clin Cancer Res; 2006 Nov; 12(22):6637-42. PubMed ID: 17121882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation profiling in Barrett's esophagus and esophageal adenocarcinoma reveals unique methylation signatures and molecular subclasses.
    Kaz AM; Wong CJ; Luo Y; Virgin JB; Washington MK; Willis JE; Leidner RS; Chak A; Grady WM
    Epigenetics; 2011 Dec; 6(12):1403-12. PubMed ID: 22139570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.